PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 169 filers reported holding PTC THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.79 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $6,796,000 | -12.4% | 201,486 | -29.7% | 0.03% | -17.6% |
Q1 2018 | $7,759,000 | +1221.8% | 286,743 | +714.6% | 0.03% | +1033.3% |
Q4 2017 | $587,000 | -31.5% | 35,200 | +97.8% | 0.00% | -25.0% |
Q2 2015 | $857,000 | -7.9% | 17,800 | +16.3% | 0.00% | -50.0% |
Q1 2015 | $931,000 | – | 15,300 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RTW INVESTMENTS, LP | 7,235,196 | $162,140,742 | 3.42% |
Camber Capital Management LP | 3,400,000 | $76,194 | 2.51% |
ARMISTICE CAPITAL, LLC | 6,150,000 | $137,821,500 | 2.11% |
GREAT POINT PARTNERS LLC | 500,000 | $11,205,000 | 2.04% |
COWEN AND COMPANY, LLC | 799,511 | $17,917,041 | 1.25% |
GEORGE KAISER FAMILY FOUNDATION | 45,816 | $6,491,211 | 1.22% |
SPHERA FUNDS MANAGEMENT LTD. | 218,459 | $4,895,666 | 0.89% |
SECTORAL ASSET MANAGEMENT INC | 187,016 | $4,191,029 | 0.82% |
Nebula Research & Development LLC | 21,858 | $489,838 | 0.26% |
Phocas Financial Corp. | 64,701 | $1,450,000 | 0.21% |